Multipark

Faculty of Medicine | Lund University

Menu

MultiPark

MOVING SCIENCE FORWARD

MultiPark is a strategic research area funded by the Swedish Government. Building on the strong tradition of cutting-edge research on Parkinson's and Alzheimer's diseases at Lund University, our vision is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with these disorders.

News

One of the world’s largest pharmaceutical companies, Novo Nordisk, is starting a new stem cell program for the treatment of Parkinson’s disease in close collaboration with Lund University.

Editorial by Director Gunnar Gouras - The MultiPark management looks forward to another productive year and hopes all in our environment have had nice holidays. Looking back at our annual retreat on December 1 we again thank our invited speakers, Thomas Nyström, professor at the University of Gothenburg and a leading expert on the biology of aging, and Iben Lundegaard, our new colleague and Wallenberg Molecular Medicine scholar in neuroscience. 

The MultiPark Retreat 2017 will take place on December 1 in the LUX aula in the LUX building of Lund University.

We are happy to welcome Thomas Nyström, professor at the University of Gothenburg and leading expert on the biology of aging as our keynote speaker and our new colleague Iben Lundgaard as invited speaker.

unknown 1 1

Alzheimer’s disease is characterised by so-called plaques – white clumps of the beta-amyloid protein in the brain. The prevailing line of argument has therefore been that patients should be treated to make the plaques disappear. This approach sounds logical, but has not resulted in any new effective medicines – and Professor of Experimental Neurology, Gunnar Gouras, thinks it could be wrong.

malin parmar

Capsules for transporting drugs, knee injuries that are really osteoarthritis, skin cells reprogrammed into nerve cells, variations in our DNA affecting the production of blood cells, and the urban sharing economy as a potential solution to our sustainability challenges. These are the research areas which have been awarded ERC Consolidator Grants from the European Research Council (ERC) in the 2017 round of awards.

Site overview